Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis
European Journal of Internal Medicine · 2024
DOI: 10.1016/j.ejim.2024.06.013 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Internal Medicine, 2024. Verfasst von Adrián Martín-Gutiérrez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Aortitis, Giant Cell Arteritis, Heart Aneurysm. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Aortitis in Giant Cell Arteritis (GCA-aortitis) is a frequent complication that may lead to aneurysms. Tocilizumab (TCZ) was approved in GCA, but the efficacy in GCA-aortitis and aneurysms has not been analyzed to date. Our aim was to assess the effectiveness and safety of TCZ in a wide series of GCA-aortitis and aneurysms. METHODS: Multicentre observational study with GCA-aortitis treated with TCZ. GCA was diagnosed by: a) ACR criteria, b) temporal artery biopsy, and/or c) imaging techniques. Aortitis was diagnosed mainly by PET/CT. Main outcomes were EULAR and imaging remission. Others were clinical remission, analytical normalization, corticosteroid-sparing effect, and the prevention and improvement of aneurysms. RESULTS: 196 patients with GCA-aortitis treated with TCZ. After 6 months, 72.2% reached EULAR remission but only 12% an imaging remission; increasing up-to 81.4% and 31.8%, respectively, at 24 months. A rapid clinical remission, ESR and CRP normalization was observed in 47.4%, 84.3% and 55.6%, at 1 month, increasing to 89.6%, 85.3% and 80.3% at 24 months, respectively. Aneurysms were present in 10 (5%) patients. Five of them required early surgery, while 3 others enlarged. No patient on TCZ therapy developed aneurysms during follow-up. CONCLUSION: In patients with GCA-aortitis treated with TCZ, a rapid and maintained clinical and analytical improvement was observed. However, there was an uncoupling between clinical and EULAR remission with imaging remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
- Department of Rheumatology, Hospital de Bellvitge, Barcelona, Spain.
- Department of Rheumatology, Complejo Hospitalario de Navarra, Pamplona, Spain.
- Department of Rheumatology, Hospital Universitario de Donosti, San Sebastián, Spain.
- Department of Rheumatology, Hospital General Universitario de Alicante, Alicante, Spain.
- Department of Rheumatology, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
Zitieren
APA
Martín-Gutiérrez, A., Loricera, J., Narváez, J., Aldasoro, V., Maiz, O., Vela, P., Romero-Yuste, S., de Miguel, E., Galíndez-Agirregoikoa, E., Fernández-López, J. C., Ferraz-Amaro, I., Sánchez-Martín, J., Moya, P., Campos, C., López-Gutiérrez, F., Castañeda, S., Blanco, R., & Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group (2024). Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2024.06.013
Vancouver
Martín-Gutiérrez A, Loricera J, Narváez J, Aldasoro V, Maiz O, Vela P, et al. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis. European Journal of Internal Medicine. 2024. doi:10.1016/j.ejim.2024.06.013
BibTeX
@article{MartnGutirrez2024,
author = {Martín-Gutiérrez, Adrián and Loricera, Javier and Narváez, Javier and Aldasoro, Vicente and Maiz, Olga and Vela, Paloma and Romero-Yuste, Susana and de Miguel, Eugenio and Galíndez-Agirregoikoa, Eva and Fernández-López, Jesús C and Ferraz-Amaro, Iván and Sánchez-Martín, Julio and Moya, Patricia and Campos, Cristina and López-Gutiérrez, Fernando and Castañeda, Santos and Blanco, Ricardo and Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group, Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group},
title = {Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis},
journal = {European Journal of Internal Medicine},
year = {2024},
doi = {10.1016/j.ejim.2024.06.013}
}
EUVIMED